Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

A district court in Ohio Friday (Sept. 29) rejected a motion by the U.S. Chamber of Commerce to halt Medicare’s drug price negotiation program, dealing industry groups a defeat in the first of several cases aiming to block the program to come before a judge.

Inside Drug Pricing Home Page

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.